Aspen to Pay UK NHS £8m In Landmark Deal Following Competition Probe
Executive Summary
Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.
You may also be interested in...
US, EU and UK Antitrust Enforcers Form Pharma Monitoring Taskforce
Antitrust regulators in the US, Europe and elsewhere say they will now collaborate on how to best assess pharmaceutical mergers, in a move that could restrict deals on grounds they excessively raise prices paid by consumers or dampen medical innovation.
UK’s CMA Issues Fines Over Fludrocortisone
The UK’s Competition and Markets Authority has issued fines of nearly £2.3m after formally concluding that three firms participated in illegal arrangements over fludrocortisone that violated competition law.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.